BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1594587)

  • 1. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.
    Trojan J; Blossey BK; Johnson TR; Rudin SD; Tykocinski M; Ilan J; Ilan J
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4874-8. PubMed ID: 1594587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.
    Trojan J; Johnson TR; Rudin SD; Ilan J; Tykocinski ML; Ilan J
    Science; 1993 Jan; 259(5091):94-7. PubMed ID: 8418502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.
    Burfeind P; Chernicky CL; Rininsland F; Ilan J; Ilan J
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7263-8. PubMed ID: 8692980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.
    Resnicoff M; Sell C; Rubini M; Coppola D; Ambrose D; Baserga R; Rubin R
    Cancer Res; 1994 Apr; 54(8):2218-22. PubMed ID: 8174129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo.
    Pu P; Liu X; Liu A; Cui J; Zhang Y
    J Neurosurg; 2000 Jan; 92(1):132-9. PubMed ID: 10616092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin A2 specifically represses insulin-like growth factor-I gene expression in C6 rat glioma cells.
    Bui T; Kuo C; Rotwein P; Straus DS
    Endocrinology; 1997 Mar; 138(3):985-93. PubMed ID: 9048599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
    Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.
    Rininsland F; Johnson TR; Chernicky CL; Schulze E; Burfeind P; Ilan J
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5854-9. PubMed ID: 9159164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA.
    Du J; Delafontaine P
    Circ Res; 1995 Jun; 76(6):963-72. PubMed ID: 7758167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression.
    Wang ZH; Ma J; Zeng BJ; Catanese VM; Samuels S; Gama Sosa MA; Kolodny EH
    Neuroendocrinology; 1997 Sep; 66(3):203-11. PubMed ID: 9380278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.
    Ly A; Francois JC; Upegui-Gonzalez LC; Swiercz B; Bedel C; Duc HT; Bout D; Trojan J
    Life Sci; 2000 Dec; 68(3):307-19. PubMed ID: 11191646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
    Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
    Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis.
    Ly A; Bouchaud C; Henin D; Sanson M; Delattre JY; Pan Y; Anthony D; Duc HT; Evrard P; Trojan J
    Neurosci Lett; 2000 Mar; 281(1):13-6. PubMed ID: 10686404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA.
    Trojan J; Duc HT; Upegui-Gonzalez LC; Hor F; Guo Y; Anthony D; Ilan J
    Neurosci Lett; 1996 Jul; 212(1):9-12. PubMed ID: 8823750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells.
    Benbassat C; Shoba LN; Newman M; Adamo ML; Frank SJ; Lowe WL
    Endocrinology; 1999 Jul; 140(7):3073-81. PubMed ID: 10385399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA.
    Resnicoff M; Li W; Basak S; Herlyn D; Baserga R; Rubin R
    Cancer Immunol Immunother; 1996 Jan; 42(1):64-8. PubMed ID: 8625368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of insulin-like growth factor-binding protein-2 in C6 glioma cells results in conditional alteration of cellular growth.
    Bradshaw SL; D'Ercole AJ; Han VK
    Endocrinology; 1999 Feb; 140(2):575-84. PubMed ID: 9927280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-stranded ribonucleic acid decreases C6 rat glioma cell numbers: effects on insulin-like growth factor I gene expression and action.
    Chacko MS; Adamo ML
    Endocrinology; 2000 Oct; 141(10):3546-55. PubMed ID: 11014207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
    Lafarge-Frayssinet C; Duc HT; Frayssinet C; Sarasin A; Anthony D; Guo Y; Trojan J
    Cancer Gene Ther; 1997; 4(5):276-85. PubMed ID: 9345599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.